Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2020;31(3):337-40
Article Links
MicroRNA155 Expression in Different Phenotypes and Genotypes of Behçet's Disease in a Sample of Egyptian Patients
Sally S. Hassouna1, Manal Y. Tayel1, Ashraf I. Alzawawy2, Dalal M. Elkaffash3, Ahmed M. Abdel Hadi1, Eman H. Elsayed3, Rowayda M. Amin2, Eman Tayae2, Alya Elkayal2, Asmaa Nasr2
Authors Information

1. Internal Medicine Department, Rheumatology and Immunology Unit, Faculty of Medicine, Alexandria University, Alexandria, Egypt

2. Clinical and Chemical Pathology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt

3. Opthalmology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt

Sally S. Hassouna, Dalal M. Elkaffash,  Eman Tayae 

Keywords: Behçet's, microRNA155, phenotypes
References
  1. Sakane T, Takeno M, Suzuki N, Inaba G. BD disease. N Engl J Med 1999;341:1284-91.
  2. Shahriyari E, Vahedi L, Roshanipour N, Jafarabadi MA, Khamaneh A, Laleh MG. Exploring the association of IL-10 polymorphisms in Behcet’s disease. J Inflamm 2019;16:26.
  3. Morton LT, Situnayake D, Wallace GR. Genetics of Behçet's disease. Curr Opin Rheumatol 2016;28:39-44.
  4. O’Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Natr Rev Immunol 2010;10:111-22.
  5. Hassouna SS, Tayel MY, Elkaffash DM, Abdelhady AM, Elsayed EH. MicroRNA155 Expression in Relation to BDCAF Scored Behҫet’s Disease in an Egyptian Patients’ Sample. Open Rheumatol 2018;12:115-22.
  6. Zhou Q, Xiao X, Wang C, Zhang X, Li F, Zhou Y, et al. Decreased microRNA-155 expression in ocular BD disease but not in Vogt Koyanagi Harada syndrome. Invest Ophthalmol Vis Sci 2012;53:5665-74.
  7. Yamakawa Y, Sugita Y, Nagatani T, Takahashi S, Yamakawa T, Tanaka S, et al. Interleukin-6 (IL-6) in patients with BD disease. J Dermatol Sci 1996;11:189-95.
  8. Emmi G, Talarico R, Lopalco G, Cimaz R, Cantini F, Viapiana O, et al. Efficacy and safety profile of anti-interleukin-1 treatment in BD disease: a multicenter retrospective study. Clin Rheumatol 2016;35:1281-6.
  9. Martinez-Nunez RT, Louafi F, Sanchez-Elsner T. The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1). J Biol Chem 2011;286:1786-94.
  10. Lu LF, Thai TH, Calado DP, Chaudhry A, Kubo M, Tanaka K, et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells through targeting SOCS1. Immunity 2009;30:80-91.
  11. Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA, et al. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci USA 2009;106:2735-40.
  12. Na SY, Park MJ, Park S, Lee ES. MicroRNA-155 regulates the Th17 immune response by targeting Ets-1 in BD disease. Clin Exp Rheumatol 2016;34:S56-63.
  13. O'Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, Chaudhuri AA, et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 2010;33:607-19.
  14. Blüml S, Bonelli M, Niederreiter B, Puchner A, Mayr G, Hayer S, et al. Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice. Arthritis Rheum 2011;63:1281-8.